The AstraZeneca vaccine is ineffective in the new South African coronavirus variant.
I know, it was known for days, the vaccine against covid-19 from the University of Oxford and the Anglo-Swedish pharmaceutical company AstraZeneca is equally effective in combating the new British variant of Sars-CoV-2, according to the latest scientific data, in the case of the southern variant -African.
According to a joint study by the British institution and a university in South Africa, cited by the newspaper “Financial Times”, this vaccine, which will arrive in Portugal on Tuesday, is less effective in less serious diseases that the South African variant of the virus can cause. “In this phase of I / II tests, the data show limited effectiveness, especially against the mild disease caused by the South African variant B.1.351,” an AstraZeneca spokesman told the British newspaper.
With regard to serious diseases that may arise from this variant, nothing can be concluded yet, explained the person in charge, since most of the volunteers who participated in these last tests were young adults without associated diseases.
– .
:quality(80)/cdn-kiosk-api.telegraaf.nl/42747426-688b-11eb-8634-0255c322e81b.jpg?resize=150%2C150&ssl=1 "Sugawara shoots AZ to victory in Emmen | Football")
![[정치]Sang-ho Woo and Bong-ju Jeong “Agree on unification of candidates under the premise of consolidation of both parties”](https://i0.wp.com/image.ytn.co.kr/general/jpg/2021/0207/202102071217554260_t.jpg?resize=150%2C150&ssl=1 "[정치]Sang-ho Woo and Bong-ju Jeong “Agree on unification of candidates under the premise of consolidation of both parties”")